MedPath

Peritoneal Dialysis Daily Versus Six Days Per Week

Not Applicable
Withdrawn
Conditions
Peritoneal Dialysis
Interventions
Other: Skip one day of peritoneal dialysis treatment
Registration Number
NCT06399848
Lead Sponsor
Stanford University
Brief Summary

The study will enroll patients receiving daily peritoneal dialysis who have significant residual native kidney function. The investiators will visit the patients at a routinely scheduled clinic visit and again at a non-routine visit after the patients skip a single day of dialysis. Blood samples will be obtained and a quality of life questionnaire will be administered at both visits.

The primary aim will be to determine whether the patients would prefer daily treatment or being allowed to skip one day per week.

Other aims will be to determine the effect of skipping a day on plasma levels of urea nitrogen and creatinine.

Detailed Description

The patients' preference will be assessed by asking the simple question would you prefer to perform peritoneal dialysis daily of six days per week.

The quality of life questionnaire to be used will be the Dialysis Symptom Index (DSI) which has a range of 0 to 150 with a high score reflecting worse quality of life.

The chemical to be measured will be the plasma urea nitrogen in mg/dl and the plasma creatinine in mg/dl as measured by the clinical laboratory.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Daily treament with peritoneal dialysis and residual native kidney funciton with residual urea clearance greater than 2 ml/min.
Exclusion Criteria
  • less than 3 months on peritoneal dialysis
  • recent change in the dialysis prescriptoin
  • recent peritonitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Peritoneal Dialysis DailySkip one day of peritoneal dialysis treatmentEach patient will compare their regular daily treatment with the effect of skipping a single day of treatment. There will be no other intervention.
Primary Outcome Measures
NameTimeMethod
Patient's preference for treatment regimenTwo weeks per patient

Patient's stated preference for dialysis daily versus six days per week

Secondary Outcome Measures
NameTimeMethod
Plasma solute levelsTwo weeks per patient

Plasma levels of urea nitrogen and creatinine.

SymptomsTwo weeks per patient

Quality of Life as assessed by a questionnaire

© Copyright 2025. All Rights Reserved by MedPath